Bruce Thompson, PhD
As the senior biostatistician at C-TASC, Dr. Thompson has over 25 years of experience with multicenter clinical trials. During his esteemed career, Dr. Thompson has co-authored more than 85 articles in peer-reviewed journals. Currently, he is the Principal Investigator (PI) for three National Institutes of Health (NIH) studies. Additionally, Dr. Thompson has developed the statistical analyses required to shape the clinical design of these studies and other large clinical trials coordinated by C-TASC. Dr. Thompson has a BA in Microbiology from the University of Missouri and a PhD in Biostatistics from Johns Hopkins University.
Chris Donhauser, MBA
As the C-TASC Chief Financial Officer, Mr. Donhauser is responsible for overseeing the administrative functions of C-TASC. For over 25 years, he has worked on grant and contract administration related to clinical trials. Mr. Donhauser is expert with Federal Acquisition Regulations (FAR) and Federal Grants Management policies and has been responsible for numerous contract/grant business proposals, contract/grant negotiations, indirect cost proposals and audits of contract and grant budgets and proposals. Mr. Donhauser has an undergraduate degree in accounting and has a working knowledge of Office of Management and Budget (OMB) Circulars (A21, A110, A-122, and A-133) and FAR cost principles.
Mr. Donhauser is the former Treasurer of the Society for Clinical Trials and a member of the National Contract Management Association (NCMA). He has a BS in Accounting from the Villanova University and a MBA from the University of Baltimore.
Independent Board Members
- Genell Knatterud, PhD - Chair Emerita
- Mark Blum, Esq - Secretary
- Norma Lynn Fox, PhD